Best practice management of CINV in oncology patients: I. Physiology and treatment of CINV. Multiple neurotransmitters and receptors and the need for combination therapeutic approaches.

The journal of supportive oncology

Volumn 8, Issue 2 Suppl 1, 2010, Pages 5-9

  Frame, David G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; APREPITANT; CELL SURFACE RECEPTOR; CYTOCHROME P450 2D6; MORPHOLINE DERIVATIVE;

CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; GENETICS; HUMAN; NAUSEA; NEOPLASM; PHYSIOLOGY; REVIEW; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; CYTOCHROME P-450 CYP2D6; DRUG THERAPY, COMBINATION; HUMANS; MORPHOLINES; NAUSEA; NEOPLASMS; NEUROTRANSMITTER AGENTS; RECEPTORS, CELL SURFACE; VOMITING;

EID: 77955910656     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)